These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20096774)

  • 21. Paternal Lake Ontario fish consumption and risk of conception delay, New York State Angler Cohort.
    Buck GM; Mendola P; Vena JE; Sever LE; Kostyniak P; Greizerstein H; Olson J; Stephen FD
    Environ Res; 1999 Feb; 80(2 Pt 2):S13-S18. PubMed ID: 10092415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands.
    Schirm E; Pedersen L; Tobi H; Nielsen GL; Sørensen HT; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):609-13. PubMed ID: 15362083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paternal organic solvent exposure and adverse pregnancy outcomes: a meta-analysis.
    Logman JF; de Vries LE; Hemels ME; Khattak S; Einarson TR
    Am J Ind Med; 2005 Jan; 47(1):37-44. PubMed ID: 15597360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calls to a Major Teratogen Information Service Regarding Exposures During Breastfeeding.
    Hegedus E; Oakes DJ; Hill M; Ritchie HE; Kennedy DS
    Breastfeed Med; 2019 Nov; 14(9):674-679. PubMed ID: 31368784
    [No Abstract]   [Full Text] [Related]  

  • 26. Paternal exposure to methotrexate and pregnancy outcomes.
    Beghin D; Cournot MP; Vauzelle C; Elefant E
    J Rheumatol; 2011 Apr; 38(4):628-32. PubMed ID: 21239747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactation safety recommendations and reliability compared in 10 medication resources.
    Akus M; Bartick M
    Ann Pharmacother; 2007 Sep; 41(9):1352-60. PubMed ID: 17623757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risks of infant mortality and of deaths due to congenital malformation in the offspring of male electronics workers.
    Sung TI; Wang JD; Chen PC
    Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):119-24. PubMed ID: 18770860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Childrens Cancer Group.
    Shu XO; Reaman GH; Lampkin B; Sather HN; Pendergrass TW; Robison LL
    Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):645-53. PubMed ID: 7881337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paternal drug use: before and during pregnancy.
    Crijns I; Bos J; Knol M; Straus S; de Jong-van den Berg L
    Expert Opin Drug Saf; 2012 Jul; 11(4):513-8. PubMed ID: 22439857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation.
    Gendron MP; Martin B; Oraichi D; Bérard A
    Eur J Clin Pharmacol; 2009 May; 65(5):523-31. PubMed ID: 19169677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paternal occupation and neural tube defects: a case-control study based on the Oxford Record Linkage Study register.
    Fear NT; Hey K; Vincent T; Murphy M
    Paediatr Perinat Epidemiol; 2007 Mar; 21(2):163-8. PubMed ID: 17302646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azathioprine treatment during lactation.
    Christensen LA; Dahlerup JF; Nielsen MJ; Fallingborg JF; Schmiegelow K
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1209-13. PubMed ID: 18761704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory bowel disease: management issues during pregnancy.
    Ferrero S; Ragni N
    Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services.
    Schaefer C
    Congenit Anom (Kyoto); 2011 Mar; 51(1):6-11. PubMed ID: 21158950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
    Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
    Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
    Diav-Citrin O; Okotore B; Lucarelli K; Koren G
    Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motherisk--a new approach to antenatal counselling of drug/chemical exposure.
    Koren G; Feldman Y; Shear N
    Vet Hum Toxicol; 1986 Dec; 28(6):563-5. PubMed ID: 3788043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.